Skip to main content

Purpose & Achievements

Fighting Cancer

At the Weizmann Institute of Science, more than 50 research groups focus on developing better ways to prevent, diagnose, and treat cancer. In fact, nearly half of Weizmann’s life sciences research is cancer-related. Institute research has provided critical knowledge about cancer in general – Weizmann scientists were the first to demonstrate that cancer can grow in stages – as well as about specific cancers, such as breast, lung, and prostate. The Institute’s collaborative teams are working to turn basic research into powerful diagnostic tools, drugs, and therapies to fight cancer – and win.

Weizmann by the numbers

  • We were first to clone p53, the gene involved in over 50% of all cancers

  • Prof. Hadassa Degani developed an MRI-based method called three time point (3TP) that identifies cancer without the need for painful biopsies. It is FDA approved for diagnosing breast and prostate cancer.
  • Our research led to the world’s first bone-marrow transplant between incompatible people

  • Over 60 research groups focus on cancer – that’s ~40% of all our life-science research